Search

everythinglearnresearchcommunity

for

Search:↓

Early male hair loss might signal higher heart disease risk.

Older age and prostatic hyperplasia in males increase the risk of hemorrhagic cystitis after stem cell transplantation.

Societal pressure for the perfect body leads to health risks and disorders.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Diagonal earlobe and preauricular creases may indicate higher coronary artery disease risk in men.

Recognizing myxedema coma is crucial due to its high risk and unusual symptoms.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Dialysis patients benefit from water-soluble vitamins but need careful management to avoid risks.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

Surgery is the main treatment for liver hydatidosis, but has risks; albendazole is the most effective drug but can have side effects.

Elderly people, especially with chronic conditions, are more at risk of severe COVID-19 complications and need preventive care and social support.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Dengue is more severe in children than adults, with higher risks of serious complications and death.

ACTH-dependent Cushing's syndrome linked to metastatic cervical cancer is rare and has high risks.

Metformin is safe in early pregnancy for women with PCOS and may reduce certain risks.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Males had more severe COVID-19 symptoms, but their risk of death was only slightly higher than females.

COVID-19 symptoms range from mild to severe, with older adults at higher risk.

Metastatic cervical cancer can cause rare, severe Cushing's syndrome with high risk of death.

The treatment successfully reopened blood flow in most patients and extended the use of their dialysis access with low risk.

Age, health conditions, race, and gender affect COVID-19 risk.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Patients with deficiency syndrome, especially qi deficiency, have a higher risk of type 2 heart attacks.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Anorexia Nervosa and Bulimia Nervosa are complex eating disorders with increasing incidence among young females, significant morbidity, and varying mortality rates, requiring more research for better treatment.

Acne is not a key diagnostic feature for PCOS, postadolescent men with acne may have insulin resistance, melanoma patients often have few moles, tumor size in CSCC indicates higher risk of serious outcomes, and hidradenitis suppurativa is linked to higher risk of heart problems and death.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.